Mortality rates among South African patients infected with HIV who take antiretroviral therapy (ART) for longer than 2 years are now comparable with those of North American patients, reports an international team of researchers (Boulle A et al. PLoS Med. 2014;11:e1001718).
In a prospective cohort study, the researchers compared survival data from 4 cohorts in South Africa, 6 in North America, and 9 in Europe; adults were followed up for up to 4 years after starting ART at some point during the period between 2001 and 2010. (The South African cohorts were linked to the national population register, which allowed the vital status of patients lost to follow-up to be obtained.)
Friedrich MJ. Mortality Rates Decreasing for South Africans Taking ART. JAMA. 2014;312(15):1503. doi:10.1001/jama.2014.13961